Do you want to publish a course? Click here

Assessing the compliance of end-stage renal disease patients with treatment regimens

تقييم التزام مرضى الداء الكلوي النهائي بالنظام العلاجي الموصوف

1158   0   21   0 ( 0 )
 Publication date 2015
and research's language is العربية
 Created by Shamra Editor




Ask ChatGPT about the research

Compliance of treatment regimens considers one of the challenge the end-stage renal disease patients, because of its highly cost related to medication, sessions, diets and the life style modification. Objective: to assess the compliance of end-stage renal disease patients with treatment regimens. Setting: The study was carried out in all the hemodialysis departments in the governmental hospitals in Lattakia. These were Al-Assad Hospital- Public Lattakia Hospital- Military Hospital- Jablah Public Hospital- Al-Kurdaha Public Hospital- Al-Hafa Public Hospital. Subjects: the study consisted 230 patients of the hemodialysis department in the time of study from the first of November to April 2014. Tool: patients were interviewed individually to collect the necessary data using tool I, their compliance with treatment regimen were assessed using tool II. Results: only 2.17% of the patients were compliance with prescribed treatment regimen. Their compliance was affected by some factors like the hospital where they got sessions, monthly income, and with the date of beginning treatment.


Artificial intelligence review:
Research summary
تعتبر مشكلة الالتزام بالنظام العلاجي من أبرز التحديات التي تواجه مرضى الداء الكلوي النهائي، نظرًا للتكاليف المرتفعة المرتبطة بالأدوية، وجلسات التحال الدموي، والتغذية، والتعديلات في نمط الحياة. هدفت الدراسة إلى تقييم مدى التزام مرضى الداء الكلوي النهائي بالنظام العلاجي الموصوف. أجريت الدراسة في أقسام التحال الدموي في المشافي الحكومية بمحافظة اللاذقية، وشملت 230 مريضًا. تم جمع البيانات عبر مقابلات مستقلة باستخدام استمارات متخصصة لتقييم الالتزام. أظهرت النتائج أن 2.17% فقط من المرضى كانوا ملتزمين بالنظام العلاجي الموصوف، وتأثر الالتزام بعوامل مثل المشفى الذي يخضع فيه المريض للعلاج، والدخل الشهري، وتاريخ بدء العلاج. أوصت الدراسة بضرورة إعداد برامج تثقيفية مستمرة للمرضى حول أهمية الالتزام بالنظام العلاجي وتزويد وحدات التحال الدموي بكتيبات توضيحية.
Critical review
دراسة نقدية: تعتبر هذه الدراسة مهمة في تسليط الضوء على مشكلة الالتزام بالنظام العلاجي لدى مرضى الداء الكلوي النهائي، إلا أن هناك بعض النقاط التي يمكن تحسينها. أولاً، كان من الأفضل توسيع نطاق الدراسة لتشمل مشافي من مناطق مختلفة لضمان تمثيل أوسع. ثانيًا، لم تتناول الدراسة بشكل كافٍ العوامل النفسية والاجتماعية التي قد تؤثر على التزام المرضى. ثالثًا، كان من الممكن استخدام أدوات تقييم أكثر تنوعًا وشمولية للحصول على نتائج أكثر دقة. وأخيرًا، يجب أن تتضمن التوصيات استراتيجيات محددة لتحسين الدعم النفسي والاجتماعي للمرضى.
Questions related to the research
  1. ما هي نسبة المرضى الملتزمين بالنظام العلاجي الموصوف في الدراسة؟

    نسبة المرضى الملتزمين بالنظام العلاجي الموصوف كانت 2.17% فقط.

  2. ما هي العوامل التي تؤثر على التزام المرضى بالنظام العلاجي؟

    تأثر الالتزام بعوامل مثل المشفى الذي يخضع فيه المريض للعلاج، والدخل الشهري، وتاريخ بدء العلاج.

  3. ما هي التوصيات التي قدمتها الدراسة لتحسين الالتزام بالنظام العلاجي؟

    أوصت الدراسة بإعداد برامج تثقيفية مستمرة للمرضى حول أهمية الالتزام بالنظام العلاجي وتزويد وحدات التحال الدموي بكتيبات توضيحية.

  4. ما هي الأدوات المستخدمة في جمع البيانات في هذه الدراسة؟

    تم جمع البيانات عبر مقابلات مستقلة باستخدام استمارات متخصصة لتقييم الالتزام.


References used
HOWARD A, O'BRIEN D. Targeted Intervention to Improve Compliance in an Urban Hemodialysis population . Nephrology News & Issues 1999; 13(2): 31–4
DENHAERYNCK K, MANHAEVE D, ET.AL. Prevalence and Consequences of No adherence to Hemodialysis Regimens. American Journal of Critical Care 2007; 16(3): 222-36
GUERRA-GUERRERO V, SANHUEZA-ALVARADO O, CACERES-ESPINA M. Quality of Life in People with Chronic Hemodialysis: Association with Sociodemographic, Medical-clinical and Laboratory Variables. Latino-Am. Enfermagem 2012; 20(5): 838-46
rate research

Read More

Although complications of arteriovenous fistula infrequent, but they occur, the most important and common complications are: thrombosis, infection, stenosis vascular, bleeding, aneurysm, ischemia. It was observed that preparation and good care of AVF have an important role in reducing complications in addition to accelerate the maturation of arteriovenous fistula. Implementing A protocol of Postoperative Arteriovenous Fistula Care Contributes in preventing complications and improve the maturation of arterial venous connection. Objective: This study was conducted to determine the effect of the application of the policy of nursing care on the clinical outcomes of the arterial venous connection postoperatively in patients with end stage renal disease. Goal: the aim of the present study was to determine the effect of Implementing A Protocol Of Postoperative Arteriovenous Fistula Careon clinical outcomes in patients with end stage renal disease. Materials and Methods: the study was conducted at AL-Assad University Hospital (Lattakia), a convent sample of 20 patientsin the renal dialysis department and the Department of Surgery. Clinical results for AVF were evaluated and the results of application policy of nursing care to of AVF in the control and experimental groups after 40 days of follow-up by using tow development tools: Sociodemographic Data and Arteriovenous Fistula Assessment Sheet. Results: our results demonstrated important of application of A Protocol Of Postoperative Arteriovenous Fistula Care. It decreased the complications in the experimental group and improve maturation of AVF mostly in the twentieth day of the study, while there was complications higher and delay in the maturation of AVF to the fortieth day of the study and after in the control group, which left for routine hospital. Conclusions and recommendations: our present study results advice to apply a protocol of Postoperative Arteriovenous Fistula Care because its affect in decrease and preventing complication in addition to improve maturation of AVF on ESRD patients
Early and accurate detection of kidney involvement in primary and secondary glomerulopathy, and therapeutic regimen mayimprove outcomes. Renal biopsy is required for definitive diagnosisof renal disease. This study investigated whether patients with proteinuria < 1500 my/24 h without ARF have significant renal disease and should be biopsied. 50 patientsunderwent kidney biopsies during 2011-2013 in Al-Assad University Hospital and Al-Mousah University Hospital in Damascus. Sixteen of them have 24-h urine protein < 1500 mg andnormal kidney function.Female to male ratio was 3:1. Five patients(31.25%) have MN, 3 patients (18.75%) have FSGS, 2 patients (12.5%) have MCD, one case (6.25%) MPGN, and finely 5 patients (31.25%) have LNfrom which there is a case with class I,2 cases with class III(superimposed classV),and a case with IV(superimposed classV), and one case with class V.Out of 8 patients without hematuria at the time of biopsy, 2 (25%) had MN, 2 (25%) had FSGS,one patient(12.5%) MCD, 3 patients(37.5%) had LN.Three patients (18.75%) hadproteinuria <500 mg/24 h, andwere diagnosed with (MN,MCD,MPGN).Our findings showa significant renal involvement(MN-FSGS-MPGN-LN), whichreveals the importanceof conducting biopsyearly and routinely in the patient population.
This study was conducted to determine the prevalence and stages of chronic kidney disease and to identify common causes of chronic kidney disease in patients as well as the study of risk factors for the disease. The study included 1314 patients have been admitted to the Department of Internal Medicine at al-Assad University Hospital in Lattakia where they were diagnosed with chronic renal disease patients at 120 of them by 9.1%. The causes of chronic kidney disease were: diabetes 41.7%; hypertension 30%; Glomerulonephritis 11.7%; obstructive uropathy 5%; and Glomerugenetic disease 3.3%; mm3.3%; polycystic kidney d isease3.3% ; idiopathic 1.7%. Chronic kidney disease stages 1; 2; 3; 4; 5; were: 10%; 21.7%; 33.3% 20%; 15% respectively. Risk factors were: advanced age (over 50) 75%; high blood sugar 53.3%; lack of blood albumin 65%; hypertension 38.3%; family history of chronic kidney disease 25%; high triglycerides and cholesterol 11.7% .
Back pound: Patients with end stage renal disease (ESRD) and lower urinary tract anomalies (LUTA) are often considered high risk for renal transplantation. Methods and subjects: To evaluate the degree of risk, we have reviewed our experience of 17 p atients with (ESRD) and (LUTA). The study was carried out in Almoussat university hospital, between 5/ 2003 and 5/2009. After a detailed urological assessment, the patients had been undergone either non-continent cutaneous diversion (Bricker) (Two patients) or continent cutaneous diversion with bladder augmentation (14 patients), before renal transplantation. Results: The patient and graft survival rates were 84.62% and 100%, respectively. The presence of an ileal conduit did not adversely affect graft survival. And the commonest complication was persistent urinary tract infection, which occurred in all patients (100%), but didn’t cause any graft loss. However two patients died because of systemic infections and their graft function was good. Conclusion: Renal transplantation is a satisfactory option for patients with ESRD due to LUTA, but it is important to carry out detailed urological assessment prior to the transplant procedure.
Renal diseases are an important medical subject because of their prevalence, so to know frequency of glomerular diseases in Syria and compare it with international studies we studied 261 renal biopsies over a period (1/1/2007–31/12/2012), in Al As sad Hospital of the University in Damascus, investigated by light microscopy immunofluorescence. One hundred and ten cases (59.8%) were primary glomerulonephritis from 184 cases of glomerular disease focal/segmental glomerulosclerosis FSGS was the most common type of primary glomerulonephritis found (30.9%) of primary glomerulonephritis), followed by membranous nephropathy(MN) in 29.1 % , IgAnephropathy (IgAN) in 10%, then membranoproliferative glomerulonephritis (MPGN) and minimal change disease(MCD) 9.1% and, crescentic glomerulonephritis (CerGN) in 6.4% and finally postinfectious glomerulonephritis (PIGN) 5.5 % of the secondary glomerulonephritis were (74 cases constituting 40.2% of the biopsies) lupus nephritis(LN) was the most frequently diagnosed disease (85.1% of secondary glomerulonephritis) diabetic nephropathy (DN) was found in 8.1% of cases amyloidosis (AMD) in 6.8%.
comments
Fetching comments Fetching comments
Sign in to be able to follow your search criteria
mircosoft-partner

هل ترغب بارسال اشعارات عن اخر التحديثات في شمرا-اكاديميا